| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |